[In vitro perfusion of the human utero-tubo-ovarian unit. 1. Evaluation of experimental conditions and the studies of the early stage of preganacy and trophoblastic neoplasia].
D002245:Carbon Dioxide / Q000378:metabolism; D006063:Chorionic Gonadotropin / Q000378:metabolism; D004247:DNA / Q000096:biosynthesis; D004576:Electromyography; D005187:Fallopian Tubes / Q000378:metabolism*; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D008722:Methods; D010053:Ovary / Q000378:metabolism*; D010101:Oxygen Consumption; D010477:Perfusion; D010928:Placental Lactogen / Q000378:metabolism; D011247:Pregnancy; D011773:Pyruvates / Q000378:metabolism; D012313:RNA / Q000096:biosynthesis; D012334:RNA, Neoplasm / Q000096:biosynthesis; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014316:Tritium; D014328:Trophoblastic Neoplasms / Q000378:metabolism*; D014327:Trophoblasts / Q000378:metabolism; D014599:Uterus / Q000378:metabolism* / Q000502:physiology
D006063:Chorionic Gonadotropin; D011773:Pyruvates; D012334:RNA, Neoplasm; D014316:Tritium; D002245:Carbon Dioxide; D012313:RNA; D004247:DNA; D010928:Placental Lactogen; D013936:Thymidine